The National Institute on Aging at the National Institutes of Health awarded the UMKC School of Medicine Vision Research Center a five-year, $1.335 million grant to support the development of new drug therapies for protecting nerve cells from degeneration caused by chronic diseases.
Peter Koulen, Ph.D., professor and Felix and Carmen Sabates Missouri Endowed Chair in Vision Research at the School of Medicine and director of Basic Research at the VRC, is the lead investigator. The project is a collaboration of researchers at UMKC, the University of North Texas Health Science Center and West Virginia University, using interdisciplinary and interprofessional research strategies developed by the NIH.
The ultimate goal will be to develop novel therapies to specifically target the prevention and treatment of disorders affecting nerve cells. Koulen said that an essential element of developing these urgently needed new therapies is to understand how nerve cells respond to environmental and physiological stimuli and subsequently interact within other cells.
For additional details, visit UMKC Today.